Key result
After propensity-score matching, 1-year survival rates were similar between patients undergoing TAVR with severe mitral regurgitation and moderate-severe mitral regurgitation.
Why the study?
To compare 1-year outcomes after TAVR between patients with moderate-severe MR and severe MR preoperatively using nationwide registry data.
Does preoperative moderate-severe mitral regurgitation compared to severe mitral regurgitation affect 1-year survival and heart failure events in patients undergoing TAVR for aortic stenosis?
Cohort (n=2,017)
Yes
Does preoperative moderate-severe mitral regurgitation compared to severe mitral regurgitation affect 1-year survival and heart failure events in patients undergoing TAVR for aortic stenosis?
In patients undergoing TAVR for aortic stenosis, having preoperative moderate-severe versus severe mitral regurgitation does not significantly impact 1-year survival or heart failure events after adjusting for baseline confounders.
Answers are grounded in this paper and cite their sources.
Similar 1-year TAVR outcomes regardless of MR severity; leaves open whether MR grading affects prognosis or warrants targeted intervention.
This study aims to compare 1-year outcomes after transcatheter aortic valve replacement (TAVR) between patients with moderate-severe MR and severe MR preoperatively using the Japan Transcatheter Valve Therapy (J-TVT) registry. Patients undergoing TAVR for aortic stenosis between August 2013 and December 2019 with preoperative mitral regurgitation of moderate-severe (group MR3) or severe (group MR4) were included. Patients with a history of valve surgery and dialysis patients were excluded. A total of 2017 patients were included, and 1-year follow-up data were obtained from the registry (follow-up rate 98.5%). Propensity-score matching between MR3 and MR4 groups was performed. All-cause mortality and the composite outcome of death and/or heart failure events were compared. Crude data showed that 1-year survival was significantly higher in the MR 3 (89.8%) than MR 4 (84.7%) groups, and freedom from 1-year mortality and heart failure events was also higher in the MR 3 (87.1%) than MR 4 (80.5%) groups (p = 0.0001). After propensity-score matching, 452 cases (226 cases each in MR 3 group and MR 4 group) were extracted. Cox regression model showed no statistical difference in the 1-year survival rate between MR 3 group (84.5%) and MR 4 group (85.5%) (p = 0.84), nor in freedom from 1-year death and/or heart failure events between MR 3 group (80.2%) and MR 4 group (81.6%) (p = 0.72). The 1-year survival rate and freedom from death and/or heart failure events were found to be similar between patients undergoing TAVR with MR grade 3 and MR grade 4.
No takes yet. Share an insight, caveat, or question.
Matsuura et al. (2024) conducted a cohort in Aortic stenosis with concomitant moderate-severe or severe mitral regurgitation (n=2,017). Severe mitral regurgitation (grade 4) vs. Moderate-severe mitral regurgitation (grade 3) was evaluated on 1-year survival rate (p=0.84). After propensity-score matching, 1-year survival rates were similar between patients undergoing TAVR with severe mitral regurgitation and moderate-severe mitral regurgitation.
Synapse has enriched 10 related papers. Consider them for comparative context: